Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

Inter-sectoral collaboration and enhanced research are crucial to address the rising burden of Non-Communicable Diseases ...